THOMPSON SIEGEL & WALMSLEY LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 171 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
THOMPSON SIEGEL & WALMSLEY LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$412,000
+86.4%
18,000
+80.0%
0.01%
+100.0%
Q3 2021$221,000
-65.9%
10,000
-80.0%
0.00%
-66.7%
Q2 2021$648,000
+60.8%
50,000
+61.3%
0.01%
+50.0%
Q1 2021$403,000
+94.7%
31,000
+106.7%
0.01%
+100.0%
Q4 2020$207,00015,0000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders